Adherium Ltd
ASX:ADR

Watchlist Manager
Adherium Ltd Logo
Adherium Ltd
ASX:ADR
Watchlist
Price: 0.002 AUD Market Closed
Market Cap: AU$10.7m

EV/EBITDA

-0.9
Current
90%
Cheaper
vs 3-y average of -9.4

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-0.9
=
Enterprise Value
AU$14.6m
/
EBITDA
AU$-12.4m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
-0.9
=
Enterprise Value
AU$14.6m
/
EBITDA
AU$-12.4m

Valuation Scenarios

Adherium Ltd is trading above its industry average

If EV/EBITDA returns to its Industry Average (39.4), the stock would be worth AU$-0.09 (4 379% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-4 379%
Maximum Upside
No Upside Scenarios
Average Downside
3 232%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple -0.9 AU$0
0%
Industry Average 39.4 AU$-0.09
-4 379%
Country Average 18.3 AU$-0.04
-2 085%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
AU$14.6m
/
Jan 2026
AU$-12.4m
=
-0.9
Current
AU$14.6m
/
Jun 2026
AU$9.4m
=
1.6
Forward
AU$14.6m
/
Jun 2027
AU$10m
=
1.5
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
NZ
Adherium Ltd
ASX:ADR
10.7m AUD -0.9 -1.1
US
Cerner Corp
LSE:0R00
31.3B USD 21.9 53.1
US
Veeva Systems Inc
NYSE:VEEV
27.5B USD 21.1 30.2
AU
Pro Medicus Ltd
ASX:PME
14.9B AUD 77.1 62.2
JP
M3 Inc
TSE:2413
1T JPY 10.1 20.8
SE
Sectra AB
STO:SECT B
51.1B SEK -131.6 95
US
Waystar Holding Corp
NASDAQ:WAY
5B USD 15.4 43.2
US
Doximity Inc
NYSE:DOCS
4.5B USD 14.8 18.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
18.6B CNY -118 -60.4
US
Vocera Communications Inc
F:V00
2.4B EUR 267.9 -328
US
Heartflow Inc
NASDAQ:HTFL
2.7B USD 0 0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
Adherium Ltd
ASX:ADR
Average EV/EBITDA: 61.2
Negative Multiple: -0.9
N/A N/A
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
21.1
28%
0.8
AU
Pro Medicus Ltd
ASX:PME
77.1
28%
2.8
JP
M3 Inc
TSE:2413
10.1
14%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -131.6 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
15.4
20%
0.8
US
Doximity Inc
NYSE:DOCS
14.8
21%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -118
36%
N/A
US
V
Vocera Communications Inc
F:V00
267.9
N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
P/E Multiple
Earnings Growth PEG
NZ
Adherium Ltd
ASX:ADR
Average P/E: 46.2
Negative Multiple: -1.1
N/A N/A
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
30.2
25%
1.2
AU
Pro Medicus Ltd
ASX:PME
62.2
29%
2.1
JP
M3 Inc
TSE:2413
20.8
16%
1.3
SE
Sectra AB
STO:SECT B
95
14%
6.8
US
W
Waystar Holding Corp
NASDAQ:WAY
43.2
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.7
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -60.4
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A

Market Distribution

Lower than 100% of companies in New Zealand
Percentile
0th
Based on 199 companies
0th percentile
-0.9
Low
4.2 — 14.7
Typical Range
14.7 — 28.5
High
28.5 —
Distribution Statistics
New Zealand
Min 4.2
30th Percentile 14.7
Median 18.3
70th Percentile 28.5
Max 518.2

Adherium Ltd
Glance View

Market Cap
10.7m AUD
Industry
Health Care

Adherium Ltd. is an international respiratory eHealth company, which is focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. The company offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.

ADR Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett